JPMorgan Chase & Co. Lowers Lexeo Therapeutics (NASDAQ:LXEO) Price Target to $10.00
Lexeo Therapeutics (NASDAQ:LXEO – Get Free Report) had its price objective lowered by stock analysts at JPMorgan Chase & Co. from $16.00 to $10.00 in a report issued on Friday,Benzinga reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target would suggest a potential upside of 262.32% from […]
Lexeo Therapeutics (NASDAQ:LXEO – Get Free Report) had its price objective lowered by stock analysts at JPMorgan Chase & Co. from $16.00 to $10.00 in a report issued on Friday,Benzinga reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target would suggest a potential upside of 262.32% from […]
